Nutritional Assesment in Patients With Cirrhosis

Sponsor
SUUMC Central Military Hospital Dr Carol Davila (Other)
Overall Status
Recruiting
CT.gov ID
NCT05729438
Collaborator
(none)
50
1
24
2.1

Study Details

Study Description

Brief Summary

This study aims to evaluated nutritional status in patiets with cirrhosis

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: BCAA

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Nutritional Assesment in Patients With Cirrhosis
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. muscle mass improvement [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • signed informed consent

  • age >18, <75 years old

  • hepatic cirrhosis diagnosis

Exclusion Criteria:
  • refuse to participate/to give consent

  • presence of musculo-skeletal disease previous diagnosed, neuropathic diseases, malignancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Suumc București București - Sector1 Romania 010825

Sponsors and Collaborators

  • SUUMC Central Military Hospital Dr Carol Davila

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bucurica Sandica, MD, SUUMC Central Military Hospital Dr Carol Davila
ClinicalTrials.gov Identifier:
NCT05729438
Other Study ID Numbers:
  • 559
First Posted:
Feb 15, 2023
Last Update Posted:
Feb 15, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2023